Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Di Stefano

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|December 16, 2017
Hormonal treatment and quality of life of prostate cancer patients: new evidenceMarcello Tucci, Gianmarco Leone, Consuelo Buttigliero, et al.
Archives of Gerontology and Geriatrics|July 26, 2008
Thyroid function in healthy centenariansD Maugeri, M S Russo, F Di Stefano, et al.
International Journal of Immunopathology and Pharmacology|September 4, 2004
Occupational asthma due to low molecular weight agentsF Di Stefano, N Verna, L Di Giampaolo, et al.
Archives of Gerontology and Geriatrics|May 1, 1995
Senile diabetes and bone mineral densityD Maugeri, P Panebianco, G Destro, et al.
Physical Review Letters|October 29, 2013
Sound and light from fractures in scintillatorsA Tantot, S Santucci, O Ramos, et al.
Archives of Gerontology and Geriatrics|July 26, 2008
Use of disphosphonates in the treatment of osteoporosis in thyroidectomized patients on levothyroxin replacement therapyP Panebianco, D Rosso, G Destro, et al.
Contact Dermatitis|September 30, 2000
Lymphocyte subset changes in blood and gastrointestinal mucosa after oral nickel challenge in nickel-sensitized womenM Di Gioacchino, P Boscolo, E Cavallucci, et al.
Minerva Urology and Nephrology|March 30, 2021
Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamideChiara Pisano, Marcello Tucci, Rosario F DI Stefano, et al.
Prostate Cancer and Prostatic Diseases|February 19, 2021
Prognostic role of the duration of response to androgen deprivation therapy in patients with metastatic castration resistant prostate cancer treated with enzalutamide or abiraterone acetateRosario F Di Stefano, Marcello Tucci, Fabio Turco, et al.
Minerva Urology and Nephrology|February 11, 2022
Prognostic factors in metastatic castration resistant prostate cancer patients treated with radium-223: a retrospective studyTiziana Angusti, Rosario F DI Stefano, Antonella Parente, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|December 16, 2017
Hormonal treatment and quality of life of prostate cancer patients: new evidenceMarcello Tucci, Gianmarco Leone, Consuelo Buttigliero, et al.
Archives of Gerontology and Geriatrics|July 26, 2008
Thyroid function in healthy centenariansD Maugeri, M S Russo, F Di Stefano, et al.
International Journal of Immunopathology and Pharmacology|September 4, 2004
Occupational asthma due to low molecular weight agentsF Di Stefano, N Verna, L Di Giampaolo, et al.
Archives of Gerontology and Geriatrics|May 1, 1995
Senile diabetes and bone mineral densityD Maugeri, P Panebianco, G Destro, et al.
Physical Review Letters|October 29, 2013
Sound and light from fractures in scintillatorsA Tantot, S Santucci, O Ramos, et al.
Archives of Gerontology and Geriatrics|July 26, 2008
Use of disphosphonates in the treatment of osteoporosis in thyroidectomized patients on levothyroxin replacement therapyP Panebianco, D Rosso, G Destro, et al.
Contact Dermatitis|September 30, 2000
Lymphocyte subset changes in blood and gastrointestinal mucosa after oral nickel challenge in nickel-sensitized womenM Di Gioacchino, P Boscolo, E Cavallucci, et al.
Minerva Urology and Nephrology|March 30, 2021
Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamideChiara Pisano, Marcello Tucci, Rosario F DI Stefano, et al.
Prostate Cancer and Prostatic Diseases|February 19, 2021
Prognostic role of the duration of response to androgen deprivation therapy in patients with metastatic castration resistant prostate cancer treated with enzalutamide or abiraterone acetateRosario F Di Stefano, Marcello Tucci, Fabio Turco, et al.
Minerva Urology and Nephrology|February 11, 2022
Prognostic factors in metastatic castration resistant prostate cancer patients treated with radium-223: a retrospective studyTiziana Angusti, Rosario F DI Stefano, Antonella Parente, et al.
Pageof 9